GSTM1 and chronic myelogenous leukemia, BCR-ABL1 positive: An interesting result was observed by Lordelo et al who found a positive association between CML risk with GSTM1 present genotype and that the GSTM1 null genotype decreased this risk (Lordelo et al., 2012).